The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
Open accessAbstract
While the ability of APOBEC3G to reduce the replication of a range of exogenous retroviruses is now well established, recent evidence has suggested that APOBEC3G can also inhibit the replication of endogenous retrotransposons that bear long terminal repeats. Here, we extend this earlier work by showing that two other members of the human APOBEC3 protein family, APOBEC3B and APOBEC3A, can reduce retrotransposition by the intracisternal A-particle (IAP) retrotransposon in human cells by 20-fold to up to 100-fold, respectively. This compares to an approximately 4-fold inhibition in IAP retrotransposition induced by APOBEC3G. While both APOBEC3G and APOBEC3B specifically interact with the IAP Gag protein in co-expressing cells, and induce extensive editing of IAP reverse transcripts, APOBEC3A fails to package detectably into IAP virus-like particles and does not edit IAP reverse transcripts. These data, which identify human APOBEC3A as a highly potent inhibitor of LTR-retrotransposon function, are the first to ascribe a biological activity to APOBEC3A. Moreover, these results argue that APOBEC3A inhibits IAP retrotransposition via a novel mechanism that is distinct from, and in this case more effective than, the DNA editing mechanism characteristic of APOBEC3G and APOBEC3B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
Chiu, Y.-L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., & Greene, W. C. (2005) · Nature · doi:10.1038/nature03493 · Cited by 439
RetractedExportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003) · Genes & Development · doi:10.1101/gad.1158803 · Cited by 3,010
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 708
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
Self-citationAPOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Inhibition of Hepatitis B Virus Replication by APOBEC3G
Turelli, P., Mangeat, B., Jost, S., Vianin, S., & Trono, D. (2004) · Science · doi:10.1126/science.1092066 · Cited by 433
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., & Schwartz, O. (2005) · Nature · doi:10.1038/nature03238 · Cited by 346
Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain-Hobson, S., & Vartanian, J.-P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408223102 · Cited by 304
Bogerd, H. P., Doehle, B. P., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295
Self-citationAPOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication
Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 293
APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Perez-Caballero, D., Göttlinger, H., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 281
Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W.-S., & Pathak, V. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405761200 · Cited by 268
The Interaction between HIV-1 Gag and APOBEC3G
Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., & Kleiman, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402062200 · Cited by 244
Alce, T. M., & Popik, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400235200 · Cited by 239
Seifarth, W., Frank, O., Zeilfelder, U., Spiess, B., Greenwood, A. D., Hehlmann, R., & Leib-Mösch, C. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.341-352.2005 · Cited by 230
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
Doehle, B. P., Schäfer, A., & Cullen, B. R. (2005) · Virology · doi:10.1016/j.virol.2005.06.005 · Cited by 229
Schäfer, A., Bogerd, H. P., & Cullen, B. R. (2004) · Virology · doi:10.1016/j.virol.2004.08.006 · Cited by 223
Self-citationThe antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein
Löchelt, M., Romen, F., Bastone, P., Muckenfuss, H., Kirchner, N., Kim, Y.-B., Truyen, U., Rösler, U., Battenberg, M., Saib, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501445102 · Cited by 194
Langlois, M.-A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki343 · Cited by 181
Russell, R. A., Wiegand, H. L., Moore, M. D., Schäfer, A., McClure, M. O., & Cullen, B. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8724-8731.2005 · Cited by 177
Khan, M. A., Kao, S., Miyagi, E., Takeuchi, H., Goila-Gaur, R., Opi, S., Gipson, C. L., Parslow, T. G., Ly, H., & Strebel, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5870-5874.2005 · Cited by 177
Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells
Dewannieux, M., Dupressoír, A., Harper, F., Pierron, G., & Heidmann, T. (2004) · Nature Genetics · doi:10.1038/ng1353 · Cited by 150
Mietz, J. A., Grossman, Z., Lueders, K. K., & Kuff, E. L. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3020-3029.1987 · Cited by 148
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
Schumacher, A. J., Nissley, D. V., & Harris, R. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501694102 · Cited by 147
Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients
Depil, S., Roche, C., Dussart, P., & Prin, L. (2002) · Leukemia · doi:10.1038/sj.leu.2402355 · Cited by 140
APOBEC‐mediated interference with hepadnavirus production†
Rösler, C., Köck, J., Kann, M., Malim, M. H., Blum, H. E., Baumert, T. F., & von Weizsäcker, F. (2005) · Hepatology · doi:10.1002/hep.20801 · Cited by 135
Inhibition of a Yeast LTR Retrotransposon by Human APOBEC3 Cytidine Deaminases
Dutko, J. A., Schäfer, A., Kenny, A. E., Cullen, B. R., & Curcio, M. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.051 · Cited by 134
Doehle, B., Schäfer, A., Wiegand, H. L., Bogerd, H. P., & Cullen, B. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8201-8207.2005 · Cited by 132
Self-citationYi, J. M., Kim, H., & Kim, H. (2004) · Journal of General Virology · doi:10.1099/vir.0.79791-0 · Cited by 67
Assessment of retroviral activity using a universal retrovirus chip
Seifarth, W., Spieß, B., Zeilfelder, U., Speth, C., Hehlmann, R., & Leib‐Mösch, C. (2003) · Journal of Virological Methods · doi:10.1016/s0166-0934(03)00194-0 · Cited by 61
Regulated Production and Anti-HIV Type 1 Activities of Cytidine Deaminases APOBEC3B, 3F, and 3G
Rose, K. M., Marin, M., Kozak, S. L., & Kabat, D. (2005) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2005.21.611 · Cited by 60
Lindeskog, M., & Blomberg, J. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-10-2575 · Cited by 37
Cited by
Harris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551
Restricting retrotransposons: a review
Goodier, J. L. (2016) · Mobile DNA · doi:10.1186/s13100-016-0070-z · Cited by 436
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
The APOBEC Protein Family: United by Structure, Divergent in Function
Salter, J. D., Bennett, R. P., & Smith, H. C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.001 · Cited by 408
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., O’Shea, K. S., Moran, J. V., & Cullen, B. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603313103 · Cited by 375
Self-citation
Metadata
- Authors
- Bogerd, H. P.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-08
- Volume
- 34
- Issue
- 1
- Pages
- 89-95
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2130676809
- Cited by
- 273
- References
- 41
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.